Pharmaceuticals, Biotechnology and Life Sciences
— First Phase 2 Clinical Trial to Combine Immunomodulation and Antigen Suppression Approaches in HBV Cure Research — FOSTER CITY,…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–#Bomedemstat—Imago BioSciences, Inc., a clinical-stage biopharmaceutical company developing innovative treatments for myeloproliferative neoplasms, today announced that…
– Breakthrough designation is based on positive outcomes from clinical studies, and will advance the industry’s first next-generation digital therapeutic…
BURNABY, British Columbia & INDIANAPOLIS–(BUSINESS WIRE)–ARTMS Inc. (‘ARTMS’) and Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’) are pleased to announce they…
Companies aim to build confidence in COVID-19 vaccines via Uber’s global network of riders and drivers SAN FRANCISCO & CAMBRIDGE,…
Partnership bridges healthcare consumer divide enabling pharma to refocus patient recruitment budgets for better outcomes MALMÖ, Sweden & RESEARCH TRIANGLE…
Submission to FDA was based on positive data from Phase III FIDELIO-DKD study recently published in the New England Journal…
SoftBank Vision Fund 2, Alaska Permanent Fund Corporation, Altitude Life Science Ventures, Qatar Investment Authority, and Other New Investors Provide…
FREDERICK, Md.–(BUSINESS WIRE)–Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies of diseases with…
Swiss Federal Government has secured 7.5 million doses and first deliveries expected to begin in January CAMBRIDGE, Mass.–(BUSINESS WIRE)–Moderna, Inc.…